Identification and Treatment of Tuberculosis in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Review of the Literature

References

• Huaman MA, Brawley R, Ashkin D. Multidrug-resistant tuberculosis in transplant recipients: case report and review of the literature. Transplant Infect Dis. 2017;19(2):2. doi:10.1111/tid.12672
   Web of Science ®Google Scholar
• Vecino R, Santiago B, Baquero-Artigao F, et al. Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients. Pediatr Infect Dis J. 2012;31(7):774–777. doi:10.1097/INF.0b013e3182564ec722517335
   PubMed Web of Science ®Google Scholar
• Zhao Z, Leow WQ. Concurrent Hepatic Tuberculosis and Hepatic Graft-versus-host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report. Transplant Proc. 2017;49(7):1659–1662. doi:10.1016/j.transproceed.2017.03.07328774674
   PubMed Web of Science ®Google Scholar
• Yoo JW, Jo KW, Kim SH, et al. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients. Transplant Int. 2016;29(5):549–558. doi:10.1111/tri.12752
   Web of Science ®Google Scholar
• Benito N, Garcia-Vazquez E, Horcajada JP, et al. Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect. 2015;21(7):651–658. doi:10.1016/j.cmi.2015.03.01025882369
   PubMed Web of Science ®Google Scholar
• Fan WC, Liu CJ, Hong YC, et al. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study. Int j Tuberculosis Lung Dis. 2015;19(1):58–64. doi:10.5588/ijtld.14.0301
   Web of Science ®Google Scholar
• Ip MS, Yuen KY, Woo PC, et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med. 1998;158(4):1173–1177. doi:10.1164/ajrccm.158.4.97120729769278
   PubMed Web of Science ®Google Scholar
• Collaco JM, Gower WA, Mogayzel PJ. Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: overview, diagnostic considerations, and infectious complications. Pediatr Blood Cancer. 2007;49(2):117–126. doi:10.1002/pbc.2106117029246
   PubMed Web of Science ®Google Scholar
• Lee JW, Kwon HJ, Jang PS, et al. Two children with differing outcomes after treatment for pulmonary tuberculosis diagnosed after allogeneic hematopoietic stem cell transplantation. Transplant Infect Dis. 2011;13(5):520–523. doi:10.1111/j.1399-3062.2011.00641.x
   Web of Science ®Google Scholar
• George B, Mathews V, Viswabandya A, Srivastava A, Chandy M. Infections in children undergoing allogeneic bone marrow transplantation in India. Pediatr Transplant. 2006;10(1):48–54. doi:10.1111/j.1399-3046.2005.00397.x16499587
   PubMed Web of Science ®Google Scholar
• Chen CC, Huang LM, Chang YL, King CC, Lin KH. Acute respiratory distress syndrome due to tuberculosis in a child after allogeneic bone marrow transplantation for acute lymphoblastic leukemia. J Formosan Med Assoc. 1999;98(10):701–704.10575842
   PubMed Web of Science ®Google Scholar
• Biral E, Faraci M, Lanino E, et al. Mycobacterium tuberculosis pneumonia and bacteremia after allogeneic hematopoietic stem cell transplant: report of an instructive pediatric case. New Microbiol. 2012;35(3):353–357.22842607
   PubMed Web of Science ®Google Scholar
• Zhu B, Dockrell HM, Ottenhoff THM, Evans TG, Zhang Y. Tuberculosis vaccines: opportunities and challenges. Respirology. 2018;23(4):359–368. doi:10.1111/resp.1324529341430
   PubMed Web of Science ®Google Scholar
• Russo RL, Dulley FL, Suganuma L, Franca IL, Yasuda MA, Costa SF. Tuberculosis in hematopoietic stem cell transplant patients: case report and review of the literature. Int j Infect Dis. 2010;14(Suppl 3):e187–e191. doi:10.1016/j.ijid.2009.08.00119819176
   PubMed Web of Science ®Google Scholar
• Yang R, Liu M, Jiang H, et al. The epidemiology of pulmonary tuberculosis in children in Mainland China, 2009–2015. Arch Dis Child. 2019.
   Web of Science ®Google Scholar
• Campos A, Vaz CP, Campilho F, et al. Central nervous system (CNS) tuberculosis following allogeneic stem cell transplantation. Bone Marrow Transplant. 2000;25(5):567–569. doi:10.1038/sj.bmt.170216310713637
   PubMed Web of Science ®Google Scholar
• Al-Anazi KA, Al-Jasser AM, Evans DA. Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study. Ann Clin Microbiol Antimicrob. 2007;6(1):16. doi:10.1186/1476-0711-6-1618021401
   PubMedGoogle Scholar
• Lam W, Viswabandya A, Hussain S, et al. A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient. Bone Marrow Transplant. 2016;51(10):1385–1386. doi:10.1038/bmt.2016.13727183093
   PubMed Web of Science ®Google Scholar
• Venkataramani V, Seif Amir Hosseini A, Schulze MH, et al. Intestinal Pneumatosis Associated with Tuberculosis after Allogeneic Hematopoietic Stem Cell Transplantation. Acta Haematol. 2017;137(1):51–54. doi:10.1159/00045243627923223
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Martino R, Trabasso P, et al. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis. 2004;38(9):1229–1236. doi:10.1086/38330715127333
   PubMed Web of Science ®Google Scholar
• Oommen S, Banaji N. Laboratory diagnosis of tuberculosis: advances in technology and drug susceptibility testing. Indian J Med Microbiol. 2017;35(3):323–331. doi:10.4103/ijmm.IJMM_16_20429063875
   PubMed Web of Science ®Google Scholar
• Aygun D, Akcakaya N, Cokugras H, Camcıoglu Y. Evaluation of Clinical and Laboratory Characteristics of Children with Pulmonary and Extrapulmonary Tuberculosis. Medicina. 2019;55:8.
   Web of Science ®Google Scholar
• Lee YM, Lee SO, Choi SH, et al. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients. J Infect. 2014;69(2):165–173. doi:10.1016/j.jinf.2014.02.01924647146
   PubMed Web of Science ®Google Scholar
• Crombie JL, LaCasce AS. Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders. Front Oncol. 2019;9:109. doi:10.3389/fonc.2019.0010930899698
   PubMed Web of Science ®Google Scholar
• Ru Y, Chen J, Wu D. Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation. Eur J Haematol. 2018;101(3):283–290. doi:10.1111/ejh.1313129949208
   PubMed Web of Science ®Google Scholar
• Bisero ED, Luque GF, Rizzo CN, Zapata AE, Cuello MS. [Pulmonary actinomycosis and tuberculosis. A comorbidity pediatric case]. Arch Argent Pediatr. 2016;114(4):e233–e236. doi:10.5546/aap.2016.e233. Spanish.27399023
   PubMed Web of Science ®Google Scholar
• Martin-Sanchez G, Drake-Perez M, Rodriguez JL, Yanez L, Insunza A, Richard C. Lymph node tuberculosis after allogeneic haematopoietic stem cell transplantation: an atypical presentation of an uncommon complication. Ecancermedicalscience. 2015;9:535. doi:10.3332/ecancer.2015.53526015804
   PubMedGoogle Scholar
• Yang A, Shi J, Luo Y, et al. Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis. Sci Rep. 2019;9(1):20402. doi:10.1038/s41598-019-56013-w31892702
   PubMed Web of Science ®Google Scholar
• Lee YJ, Bacchus M, Schmidt E, Chawla M, Barker JN, Papanicolaou GA. Paradoxical immune reconstitution inflammatory syndrome associated with disseminated tuberculosis infection in an unrelated donor cord blood transplant recipient. Transplant Infect Dis. 2018;20(3):e12889. doi:10.1111/tid.12889
   Web of Science ®Google Scholar
• Maeda T, Kusumi E, Kami M, et al. Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases. Bone Marrow Transplant. 2005;35(1):91–97. doi:10.1038/sj.bmt.170474015516933
   PubMed Web of Science ®Google Scholar
• Garces Ambrossi G, Jakubowski A, Feinstein MB, Weinstock DM. Active tuberculosis limited to foreign-born patients after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant. 2005;36(8):741–743. doi:10.1038/sj.bmt.170512916113670
   PubMed Web of Science ®Google Scholar
• Cheng MP, Kusztos AE, Bold TD, et al. Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation. Clin Infect Dis. 2019;69(5):869–872. doi:10.1093/cid/ciz04830689792
   PubMed Web of Science ®Google Scholar
• Park JH, Choi EJ, Park HS, et al. Treatment of latent tuberculosis infection based on the interferon-gamma releasing assay in allogeneic stem cell transplant recipients. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa030
   Web of Science ®Google Scholar